Tenaya Therapeutics (TNYA) Treasury Shares (2020 - 2026)

Tenaya Therapeutics has reported Treasury Shares for 7 years, with the latest figure at $2.5 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 10.85% year-over-year to $2.5 million; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (up 10.85% YoY), and the FY2025 full-year result was $1.5 million, up 13.44% from the prior year.
• Treasury Shares for Q1 2026 stood at $2.5 million, up from $1.5 million in the prior quarter.
• The five-year high for Treasury Shares was $2.5 million in Q1 2026, with the low at $61537.0 in Q3 2022.
• Average Treasury Shares over 5 years is $1.3 million, with a median of $1.4 million recorded in 2024.
• Year-over-year, Treasury Shares surged 20696.99% in 2022 and rose 10.85% in 2026.
• Tracing TNYA's Treasury Shares over 5 years: stood at $459192.0 in 2022, then jumped by 137.0% to $1.1 million in 2023, then advanced by 24.43% to $1.4 million in 2024, then gained by 13.44% to $1.5 million in 2025, then jumped by 63.9% to $2.5 million in 2026.
• The last three Treasury Shares figures came in at $2.5 million (Q1 2026), $1.5 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.

Peer Comparison